Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 Dose Finding in Mild to Moderate Persistent Asthma
NCT00890877Phase 2Completed
- Sponsor
- Oxagen
- Start
- Apr 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of timapiprant in asthma, sponsored by Oxagen. Started Apr 2009; status: completed.
02
Drugs
timapiprant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00890877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890877.